million baht or 5.09 % when compared with Q1 / 2020 which cost of sales increased in line with the increase revenue. Profit (Loss) Net Equity of shareholders of the Company for Q1 / 2021 and Q1 / 2020 was
. It is Increase 89.55 million baht or 25.76% when compared with Q3/2020 The cost of sales increased in line with the increase revenue. Profit (Loss) Net Equity of shareholders of the Company for Q3/2021
exported Cost of Sales for Q1 / 2022 and Q1 / 2021 was 290.96 million baht and 395.18 million baht, respectively, which decreased of 104.22 million baht or 26.37 % when compared with Q1 / 2021 The cost of
, respectively. It is Increase 72.10 million baht or 16.49% when compared with Q3/2021 The cost of sales increased in line with the increase revenue. Profit (Loss) Net Equity of shareholders of the Company for Q3
Q2/ 2022. However, the reason for the increase in revenue came from the company having increased sales and being able to operate at full capacity and fully exportable Cost of Sales for Q2 / 2023 and Q2
Q2/ 2022. However, the reason for the increase in revenue because the company having increased sales and being able to operate at full capacity and fully exportable Cost of Sales for Q2 / 2023 and Q2
Increase 187.34 million baht or 36.79% when compared with Q3/2022 The cost of sales increased in line with the increase revenue. Profit (Loss) Net Equity of shareholders of the Company for Q3/2023 and Q3
12.08% 56,480 116.09% Total revenues 524,868 100.00% 402,599 100.00% 122,269 30.37% Cost of sales (308,204) 58.72% (223,457) 55.50% (84,747) (37.93%) Cost of services (36,212) 6.90% (31,470) 7.82% (4,742
1,403.07 13% Cost of hospital operations 276.11 258.34 7% 1,101.98 985.67 12% Gross margin 117.88 108.76 8% 485.45 417.39 16% % Gross margin 30% 30% 0% 31% 30% 1% Administrative expenses 41.54 40.51 3
promising growth was attributed by the increase of number of patients as well as bill amount per patient. A yoy slight decline of social security revenue were mainly from high care cost revenue following the